Global Dronabinol (CAS 1972-08-3) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Dronabinol (CAS 1972-08-3) Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Dronabinol is a man-made form of cannabis (also known as marijuana). Dronabinol is used to treat loss of appetite that causes weight loss in people with AIDS. Dronabinol is also used to treat severe nausea and vomiting caused by cancer chemotherapy.

Market Overview:

The latest research study on the global Dronabinol (CAS 1972-08-3) market finds that the global Dronabinol (CAS 1972-08-3) market reached a value of USD 152.89 million in 2022. It’s expected that the market will achieve USD 243.45 million by 2028, exhibiting a CAGR of 8.06% during the forecast period.

Key Companies in the global Dronabinol (CAS 1972-08-3) market covered in Chapter 3:

Benuvia Manufacturing
KinetoChem
BOL Pharma
THC Pharm
Aphios Corporation
Noramco
Echo Pharmaceuticals
Others
Canopy Growth

In Chapter 4 and Chapter 14.2, on the basis of types, the Dronabinol (CAS 1972-08-3) market from 2018 to 2029 is primarily split into:

Purity 98%
Purity 99%

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Dronabinol (CAS 1972-08-3) market from 2018 to 2029 covers:

Capsule
Oral Liquid

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)